Koios announces release schedule for world's first cannabis infused nootropic beverage

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/

VANCOUVER, Sept. 26, 2018 /CNW/ - Koios Beverage Corp. (CSE:KBEV)(OTC: KBEVF) (the "Company" or "Koios") is pleased to announce that the world's first cannabis infused nootropic beverage is scheduled for release in November.

The new product will be a collaboration with the Company's partner Keef Brands, a division of CanCore Concepts Inc. (CanCore), and Koios' wholly owned subsidiary Cannavated Beverage Corp. Cannavated was formed specifically to license the nootropic formulas to other companies working in the area of cannabis-infused beverages.

Keef Brands will manufacture, market and sell a line of beverages that are not only infused with THC, but also contain the nootropic supplements from the Koios line of brain enhancing functional beverages. The resulting product will be the first in the world to combine cannabis infusion with nootropic supplements that enhance the consumer's mental acuity.

Keef Brands has the exclusive rights to the Cannavated nootropic formula for Colorado, with the option of expanding the licensing agreement throughout the U.S., provided it complies with all rules and regulations in the markets where cannabis has been made legal.

"We first announced this joint development project in early September, and we're very pleased to be able to announce this ground-breaking cannabis beverage will be available in Colorado in November," said Koios Chief Executive Officer Chris Miller. "This is also the first product we are releasing through our partnership with Keef Brands, one of the world leaders in the cannabis beverage industry."

Gross profits from sales - after calculating the overall Cost of Goods Sold (COGS) - will be split evenly between Cannavated and Keef Brands.

The non-carbonated cannabis beverage will be high in cannabidiol - better known as CBD - but will also contain THC, which is the psychoactive ingredient in the cannabis plant. This initial product will contain four parts CBD to one part THC, with 20 milligrams of THC in a 12-ounce can.

Cannavated was formed as a separate company that licenses its proprietary nootropic formulations to companies that independently research and produce cannabis-infused beverages.

Keef Brands, through its network of licensed manufacturing partners, is among the world's largest producers and distributors of cannabis beverages, and is the leading producer in Colorado by volume, where both companies are located.

"This partnership allows us to introduce a very exciting and very unique product to the cannabis market," said Keef Brands Chief Operating Officer Travis Tharp. "Cannavated is a market leader in the area of mind-enhancing, nootropic beverages, and we feel combining our areas of expertise has allowed us to provide our customers and distributors with a product no other producer can currently match."

Initial distribution of the new cannabis beverage will be limited to the State of Colorado, but will expand to other jurisdictions in the US once the two companies can be assured production will meet demand.

On behalf of the Board of Directors of the Company.
Chris Miller, CEO and Director, KOIOS BEVERAGE CORP.

About Koios Beverage Inc.
The Company is an emerging functional beverage company which has an available distribution network of more than 2,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well.  Koios is also the sole owner of Cannavated Beverage Corp., a subsidiary that develops beverage products and formulas for the growing cannabis market. Through its agreement with Keef Brands, the largest producer of cannabis beverages in North America, Cannavated enjoys distribution throughout the State of Colorado and is preparing for distribution in additional US states where cannabis use is legal.
Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants.  Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity.  Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.  
Koios is one of the only drinks in the world to infuse its products with MCT oil.  MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our websites: https://www.mentaltitan.com/ or koiosbeveragecorp.com

About Keef Brands
Keef Brands develops, produces, and distributes multiple cannabis-infused product lines through the Keef, OilStix, and VitaCanna brands. These products include beverages, edibles, and CO2-extracted oil for vape cartridges. Founded in Boulder, CO, the company has been at the forefront of innovation around social cannabis product development and education since 2010. In 2015, Keef's Bubba Kush Root Beer won Best Edible at the High Times Cannabis Cup, beating out over 150 entries from across the United States. Keef Brands products are currently available at over 800 dispensaries across Colorado, California, Arizona, Nevada, Puerto Rico, and Jamaica.

Forward-Looking Statements
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: (i) the timing for release of a new product line; (ii) the contents of the new product; (iii) that the new product will be the first in the world to combine cannabis infusion with nootropic supplements; and (iv) expansion of the distribution of the new product to other jurisdictions in the US. Adverse circumstances could cause delays in production and distribution of that product line. The forward-looking statements reflect management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include (i) adverse market conditions; (ii) consumer acceptance and adoption of cannabis-infused nootropic beverages as compared to other beverages; and (iii) other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

Koios has not conducted any scientific studies on the effects of Koios' products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios' products will vary from person to person. No claims or guarantees can be made as to the effects of Koios' products on an individual's health and wellbeing.

SOURCE Koios Beverage Corp.

Paula Arab, 403.889.9128, [email protected]